Yong Liu

Membrane Nanoparticles Derived from ACE2-Rich Cells Block SARS-CoV-2 Infection

Jinghong Zhao, Jingxin Kang, Song Wang, 2020, bioRxiv.

A proof of concept for neutralizing antibody-guided vaccine design against SARS-CoV-2

Nan Wang, Q. Bian, Xiangxi Wang, 2020, bioRxiv.

Immunoinformatics design of B and T-cell epitope-based SARS-CoV-2 peptide vaccination

I. Khan, S. Noreen, Yong Liu, 2023, Frontiers in Immunology.

A trimeric NTD and RBD SARS-CoV-2 subunit vaccine induced protective immunity in CAG-hACE2 transgenic mice and rhesus macaques

K. Hong, K. Lan, F. Zhu, 2021 .

The Effects of ATIR Blocker on the Severity of COVID-19 in Hypertensive Inpatients and Virulence of SARS-CoV-2 in Hypertensive hACE2 Transgenic Mice

H. Gao, L. Bao, Mingzhe Yan, 2022, Journal of Cardiovascular Translational Research.

Comparing T- and B-cell responses to COVID-19 vaccines across varied immune backgrounds

Rui Cheng, Xiangxi Wang, Yalun Li, 2023, Signal transduction and targeted therapy.